Literature DB >> 12607721

Maintaining hemodynamic stability and myocardial performance during off-pump coronary bypass surgery.

James C Hart1.   

Abstract

Patients presenting for coronary artery bypass (CAB) surgery are now older and have more comorbid conditions. Off-pump (OPCAB) methods may reduce morbidity and mortality in these higher risk patients. Multivessel surgery has been limited by the difficulty in maintaining hemodynamic stability during lateral wall vessel grafting. Techniques for providing safe access to lateral wall vessels were applied in a largely unselected group of 665 OPCAB patients with emphasis on the avoidance of right ventricular compression. Safe access to essentially all target coronary arteries was achieved with very little need for pharmacological or mechanical support. No patient required new intraaortic balloon pumping and no patient required urgent conversion to cardiopulmonary bypass. Access to essentially all target coronary arteries can be achieved and myocardial performance can be maintained when strict attention is paid to operative strategies designed to minimize right-side heart compression.

Entities:  

Mesh:

Year:  2003        PMID: 12607721     DOI: 10.1016/s0003-4975(02)04695-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Early results of off-pump coronary artery bypass: retrospective consecutive comparative study.

Authors:  Mizuho Imamaki; Atsushi Ishida; Hitoshi Shimura; Hiroki Kohno; Keiichi Ishida; Yuriko Niitsuma; Masaru Miyazaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-05

2.  Risk Factors of On-Pump Conversion during Off-Pump Coronary Artery Bypass Graft.

Authors:  Sung Sil Yoon; Jung Hee Bang; Sang Seok Jeong; Jae Hwa Jeong; Jong Soo Woo
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-10-05

3.  Development of an open-heart intraoperative risk scoring model for predicting a prolonged intensive care unit stay.

Authors:  Sirirat Tribuddharat; Thepakorn Sathitkarnmanee; Kriangsak Ngamsangsirisup; Somrat Charuluxananan; Cameron P Hurst; Suparit Silarat; Ganjana Lertmemongkolchai
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.